CRISPR/Cas9-mediated deletion of adipocyte genes associated with NAFLD alters adipocyte lipid handling and reduces steatosis in hepatocytes in vitro
American Journal of Physiology-Cell Physiology · 2023
DOI: 10.1152/ajpcell.00291.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Marta Lopez-Yus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Adipocyte and Fat Biology Laboratory (AdipoFat), Translational Research Unit, University Hospital Miguel Servet, Zaragoza, Spain. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Non-alcoholic Fatty Liver Disease, Hepatocytes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Spanish Ministry of Science, EC | European Research Council, European Molecular Biology Organization.
Abstract (Originalsprache)
Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology successfully edited genomic DNA of human adipose-derived mesenchymal stem cells (hADMSC). SOCS3, SIK1, and DUSP1 regulate adipocyte lipid handling. Silencing SOCS3, SIK1, and DUSP1 expression in hADMSC-derived adipocytes reduces hepatocyte lipid storage in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adipocyte and Fat Biology Laboratory (AdipoFat), Translational Research Unit, University Hospital Miguel Servet, Zaragoza, Spain.
- Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.
- Instituto de Investigación Sanitaria (IIS) Aragón, Zaragoza, Spain.
- Department of Medicine (H7), Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
- Gastroenterology Department, Miguel Servet University Hospital, Zaragoza, Spain.
- Departamento de Farmacología, Fisiología y Medicina Legal y Forense, Universidad de Zaragoza, Instituto Agroalimentario de Aragón (IA2) (Universidad de Zaragoza-CITA), Zaragoza, Spain.
ORCID-Profile: Jose M Arbones-Mainar
Förderung
- Spanish Ministry of Science
- EC | European Research Council
- European Molecular Biology Organization
- Gobierno de Aragón
- KI | Center for Innovative Medicine
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- MEC | Instituto de Salud Carlos III
Zitieren
APA
Lopez-Yus, M., Frendo-Cumbo, S., Del Moral-Bergos, R., Garcia-Sobreviela, M. P., Bernal-Monterde, V., Rydén, M., Lorente-Cebrian, S., & Arbones-Mainar, J. M. (2023). CRISPR/Cas9-mediated deletion of adipocyte genes associated with NAFLD alters adipocyte lipid handling and reduces steatosis in hepatocytes in vitro. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00291.2023
Vancouver
Lopez-Yus M, Frendo-Cumbo S, Del Moral-Bergos R, Garcia-Sobreviela MP, Bernal-Monterde V, Rydén M, et al. CRISPR/Cas9-mediated deletion of adipocyte genes associated with NAFLD alters adipocyte lipid handling and reduces steatosis in hepatocytes in vitro. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00291.2023
BibTeX
@article{LopezYus2023,
author = {Lopez-Yus, Marta and Frendo-Cumbo, Scott and Del Moral-Bergos, Raquel and Garcia-Sobreviela, Maria Pilar and Bernal-Monterde, Vanesa and Rydén, Mikael and Lorente-Cebrian, Silvia and Arbones-Mainar, Jose M},
title = {CRISPR/Cas9-mediated deletion of adipocyte genes associated with NAFLD alters adipocyte lipid handling and reduces steatosis in hepatocytes in vitro},
journal = {American Journal of Physiology-Cell Physiology},
year = {2023},
doi = {10.1152/ajpcell.00291.2023}
}
EUVIMED